The authors postulated that nutrient combinations that are a source of apoptosis inducers and inhibitors of compensatory cell proliferation pathways (e.g., AKT signaling) may produce high levels of programmed death in colon cancer cells. The gene discussed is AKT1; the disease is malignant colon neoplasm.